Huntington's disease like-2: Review and update

Russell L. Margolis, Dobrila D. Rudnicki, Susan E. Holmes

Research output: Contribution to journalReview articlepeer-review

Abstract

Huntington's Disease-like 2 (HDL2), like Huntington's disease (HD), is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Like HD, the neuropathology of HDL2 features prominent cortical and striatal atrophy and intranuclear inclusions. HDL2 is generally rare, accounting for only a few percent of HD-like cases in which the HD mutation has already been excluded. However, the rate is considerably higher among individuals of African ancestry, and is almost as common as HD in Black South Africans. The disorder is caused by a CTG/CAG expansion mutation on chromosome 16q24.3, with normal and expanded repeat ranges similar to HD, and a correlation between repeat length and onset age very similar to HD. Surprisingly, the available evidence suggests that HDL2 is not a polyglutamine disease. Rather, the repeat expansion is located within Junctophilin-3 in the CTG orientation. The phenotypic similarities between HD and HDL2 suggest that understanding the pathobiology of HDL2 may shed new light on the pathogenesis of HD and other disorders of striatal neurodegeneration.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalActa Neurologica Taiwanica
Volume14
Issue number1
StatePublished - Mar 2005

Keywords

  • Huntington disease
  • Huntington's disease Like-2
  • Neurodegeneration
  • Neurogenetic disease

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Huntington's disease like-2: Review and update'. Together they form a unique fingerprint.

Cite this